Plantar Fasciitis Treatment Market Synopsis

Plantar Fasciitis Treatment Market Size Was Valued at USD 1.20 Billion in 2023, and is Projected to Reach USD 2.67 Billion by 2032, Growing at a CAGR of 9.30% From 2024-2032.

The Plantar Fasciitis Treatment Market refers to the sector within the healthcare industry focused on providing therapeutic solutions for plantar fasciitis, a common condition characterized by inflammation of the plantar fascia—a thick band of tissue running along the bottom of the foot. This market encompasses various medical interventions, including medications, physical therapy, orthotic devices, and surgical procedures, aimed at alleviating pain, reducing inflammation, and restoring mobility in individuals affected by plantar fasciitis. With a growing number of people experiencing foot-related discomfort and an increasing demand for effective treatment options, the Plantar Fasciitis Treatment Market plays a vital role in addressing the healthcare needs of affected patients worldwide.

• The market for plantar fasciitis treatment is expanding at a significant rate due to a number of factors that together highlight the growing need for efficient treatments for this common foot ailment. A significant proportion of the world's population, representing a wide range of demographics, suffers from plantar fasciitis, which is defined by inflammation and pain in the heel as a result of excessive strain on the plantar fascia ligament. It is more common in athletes, people whose jobs require them to stand or walk for extended periods of time, and people who are prone to biomechanical anomalies.

• Improvements in medical technology have made it possible to create novel treatment methods that specifically address the underlying causes of plantar fasciitis, which has boosted the market's growth trajectory. These modalities cover a wide range of interventions, from more invasive choices like corticosteroid injections, extracorporeal shockwave therapy (ESWT), and surgical procedures in refractory cases to more conservative approaches like physical therapy, orthotic devices, and nonsteroidal anti-inflammatory drugs (NSAIDs). These therapeutic approaches aim to provide patients with a comprehensive approach to controlling their illness by not just addressing symptoms but also promoting tissue healing and restoring functional integrity.

• Additionally, a concentrated effort has been made to raise awareness of plantar fasciitis among patients and healthcare providers, with a focus on the significance of prompt diagnosis, customized treatment plans, and proactive management to reduce the likelihood of chronicity and recurrence. An enhanced understanding of plantar fasciitis as a curable ailment and a higher willingness on the part of patients to seek appropriate care and follow recommended interventions have resulted from this concentrated educational effort.

• But even with the obvious market potential, there are still some issues that need to be resolved in order to maximize market growth. The two biggest obstacles are the differences in access to specialized care, especially in underprivileged areas, and the comparatively high prices of sophisticated treatment modalities. In order to address these issues, healthcare practitioners, legislators, and industry stakeholders must work together to develop solutions that will increase accessibility, upgrade healthcare facilities, and promote resource equity.

• However, there are still plenty of room for innovation and expansion in the plantar fasciitis treatment industry, and major competitors are taking calculated risks to seize new opportunities and unmet demands. These initiatives cover a wide range of operations, such as partnerships for strategic research and development, mergers and acquisitions, and regional growth to reach new customers. The market for plantar fasciitis treatments is positioned for steady expansion by taking advantage of these chances and resolving current issues. This presents encouraging opportunities for stakeholders who are dedicated to enhancing patient care and enhancing clinical outcomes.

Plantar Fasciitis Treatment Market Trend Analysis

Minimally Invasive Approaches and Non-Surgical Treatments

• Less intrusive techniques and non-surgical treatments are becoming more popular in the market for treatments for plantar fasciitis. Traditional surgical operations are becoming less common. This tendency indicates that the benefits of less intrusive procedures are being recognized by the public and medical practitioners. One minimally invasive treatment that successfully reduces the symptoms of plantar fasciitis without the need for extensive incisions or drawn-out recovery periods is shockwave therapy. In addition to reducing the amount of physical trauma patients experience, this lowers the risk of surgical consequences including infections or nerve damage.

• A hallmark of non-surgical treatment for plantar fasciitis is physical therapy, which offers targeted exercises and stretching regimens meant to lessen discomfort, promote flexibility, and strengthen the muscles and ligaments supporting the foot. Physical therapy aims to treat the underlying biomechanical abnormalities and musculoskeletal issues rather than just the symptoms of plantar fasciitis. Orthotic devices, such as night splints and custom shoe inserts, improve physical therapy by providing the foot with additional support and alignment, promoting good biomechanics, and reducing the tension on the plantar fascia.

• Shockwave therapy is an additional non-invasive treatment option that is gaining popularity for the treatment of plantar fasciitis. Through the application of focused acoustic waves to the affected area, this technique reduces inflammation, promotes tissue regeneration, and activates cellular healing mechanisms. Compared to surgery, shockwave therapy is less painful and requires less recovery time, and it can be performed as an outpatient operation. It is a good option for those seeking alternatives to surgery or long-term medication use because clinical studies have shown how well it reduces the symptoms of plantar fasciitis. A broader trend toward patient-centered care and individualized treatment approaches in the management of plantar fasciitis is generally highlighted by the growing adoption of non-surgical and minimally invasive techniques.

Advancements in Orthotics, Regenerative Therapies, and Personalized Care

• Treatment options for plantar fasciitis have seen a notable upsurge in creativity, which is indicative of a deliberate attempt to address the condition's complexity and improve patient results. One noteworthy area of innovation is in the creation of specialist footwear and orthotic designs, where producers are using state-of-the-art materials and biomechanical knowledge to craft items specifically suited to the requirements of individuals suffering from plantar fasciitis. By offering customized support, cushioning, and alignment, these cutting-edge orthotics and shoes serve to relieve strain on the plantar fascia and encourage healthy foot mechanics. These items are designed to provide patients with increased comfort and mobility while lowering the risk of aggravating their illness by optimizing foot function and reducing strain.

• Apart from the progress made in orthotic technology, regenerative medicine has become a potentially fruitful area of treatment for plantar fasciitis. Injections of platelet-rich plasma (PRP), for example, use concentrated platelets from the patient's own blood to encourage tissue regeneration and repair. PRP therapy boosts the body's natural healing processes by directly sending growth factors and cytokines to the injury site, which speeds up recovery and offers long-lasting relief from plantar fasciitis symptoms. In a similar vein, stem cell therapy has enormous promise for healing injured tissues and encouraging plantar fascia tissue regeneration. This novel approach aims to repair damaged tissues, reduce inflammation, and improve overall foot function by introducing multipotent stem cells into the affected area through injections or tissue grafts. It presents a promising treatment option for patients with severe or chronic plantar fasciitis.

• Moreover, a rising emphasis on individualized and multidisciplinary approaches to care is reflected in the introduction of novel therapies and devices designed to address plantar fasciitis. More and more healthcare professionals are realizing that in order to treat patients effectively, it is necessary to have a thorough grasp of the underlying causes of each patient's disease and to create a personalized treatment plan that takes into account their individual needs and preferences. These cutting-edge methods combine cutting-edge therapeutic modalities with patient education, lifestyle changes, and continuous monitoring in an effort to treat the underlying causes of plantar fasciitis as well as its symptoms, resulting in long-term recovery and enhanced patient quality of life. All things considered, the explosion of novel medications and solutions marks a revolutionary turn in the treatment of plantar fasciitis, providing patients with new hope and opportunities for recovery from this crippling ailment.

Plantar Fasciitis Treatment Market Segment Analysis:

Plantar Fasciitis Treatment Market Segmented based on By Treatment Type, By Indication and By End-user.

By Treatment Type, Surgery (Plantar fascia release) segment is expected to dominate the market during the forecast period

• When treating severe cases of plantar fasciitis, plantar fascia release surgery is a highly effective choice. In many cases, conservative treatments such as therapy, pharmaceutical therapy, and orthotic devices may not have been able to offer long-term relief from incapacitating symptoms such persistent heel pain. Consequently, in order to treat the underlying mechanical difficulties that are causing the discomfort, patients and healthcare professionals frequently resort to surgical intervention. The goal of plantar fascia release surgery is to relieve the plantar fascia ligament's tension and strain, which is frequently the main cause of pain in cases of plantar fasciitis. The goal of the surgery is to release this ligament surgically in order to minimize inflammation and restore normal biomechanics, potentially leading to a considerable improvement in the patient's symptoms.

• The efficaciousness of plantar fascia release surgery in delivering durable relief is among the factors contributing to its predominant usage in severe cases. In cases where patients have tried all conservative measures and still don't feel well enough, surgery can be a more permanent option. Through direct intervention on the plantar fascia, this surgical method can address the underlying source of the disease and provide long-lasting outcomes, restoring mobility and quality of life to patients. When faced with severe and persistent plantar fasciitis symptoms, this treatment option is favored by both patients and healthcare experts due to its effectiveness.

• Moreover, plantar fascia release surgery is becoming a safer and less invasive procedure due to technological and medical developments. Compared to open surgeries, modern methods like endoscopic or minimally invasive procedures provide shorter recovery times and fewer complications. Patients who may have been hesitant owing to worries about invasiveness and post-operative recuperation are now more likely to accept and adopt surgical intervention. Because of this, plantar fascia release surgery continues to play a leading role in treating severe cases of plantar fasciitis, providing comfort and hope to people who have suffered from chronic heel pain.

By End-user, Hospitals segment held the largest share in 2023

• Hospitals account for the majority of end-users when it comes to plantar fasciitis therapy because of their extensive experience and wide range of situations that they regularly handle. Hospitals possess the necessary resources, skilled medical personnel, and cutting-edge diagnostic and therapeutic tools to effectively manage the intricate and frequently severe symptoms of plantar fasciitis. Individuals seeking care at hospitals benefit from having access to a wide range of treatment options under one roof, whether if their symptoms are minor discomfort or severe agony. With such a wide range of services available, patients are guaranteed individualized care regimens that, based on their unique requirements, may involve a mix of therapies, prescription drugs, and surgical procedures.

• Hospitals also function as centers for multidisciplinary collaboration between different medical specialists, such as podiatrists, physiotherapists, orthopedic surgeons, and pain management specialists. This cooperative approach makes it possible to evaluate each patient's health holistically and makes it easier to create integrated treatment plans that maximize results. Patients gain from the combined experience of these experts, who collaborate to treat underlying contributing factors including biomechanical abnormalities, gait problems, or comorbidities in addition to the immediate symptoms of plantar fasciitis. This all-encompassing strategy helps explain why hospitals are the leaders in treating plantar fasciitis in all severity ranges.

• Furthermore, hospitals are leaders in the treatment of plantar fasciitis because of their critical roles in research, innovation, and medical education. Hospital settings with academic medical centers frequently serve as the vanguard for clinical studies, surgical technique breakthroughs, and the creation of innovative medicines targeted at enhancing patient outcomes and quality of life. By consistently improving treatment procedures and using the most recent evidence-based methods, hospitals are able to maintain their leadership position in the care of plantar fasciitis due to their commitment to continuous learning and innovation. Because of this, people with plantar fasciitis, no matter how severe their disease is, tend to go to hospitals as the main source for all-inclusive, state-of-the-art care.

Plantar Fasciitis Treatment Market Regional Insights:

Asia-Pacific is Expected to Dominate the Market Over the Forecast period

• In the Asia-Pacific region, the plantar fasciitis treatment market is experiencing a significant surge in growth, establishing itself as a dominant share in the global landscape. This remarkable expansion can be attributed to a multitude of interconnected factors, each contributing to the region's evolving healthcare landscape.

• One of the primary drivers of this growth is the rapid adoption of advanced medical technologies across countries such as China, Japan, and India. These nations have witnessed substantial investments in healthcare infrastructure, coupled with a concerted effort to integrate innovative treatment modalities into clinical practice. As a result, patients in the Asia-Pacific region now have greater access to cutting-edge diagnostic tools, minimally invasive procedures, and advanced therapeutic options for managing plantar fasciitis.

• Moreover, rising healthcare spending in these countries has played a pivotal role in shaping the trajectory of the plantar fasciitis treatment market. With increasing disposable incomes and a growing middle-class population, individuals in Asia-Pacific are allocating more resources towards healthcare services, including the diagnosis and treatment of musculoskeletal disorders like plantar fasciitis. This surge in healthcare expenditure has not only enhanced patient affordability but has also spurred investments in research and development, leading to the development of novel treatment modalities tailored to the unique needs of the region.

• Furthermore, the prevalence of plantar fasciitis is on the rise in Asia-Pacific, driven by shifting demographic trends and evolving lifestyles. The region is experiencing a demographic transition characterized by an aging population, coupled with a surge in chronic health conditions associated with sedentary lifestyles, obesity, and occupational hazards. These factors have contributed to an uptick in the incidence of plantar fasciitis, thereby amplifying the demand for effective treatment options.

• Additionally, advancements in medical education and awareness campaigns have led to a greater recognition of plantar fasciitis among healthcare professionals and the general population in Asia-Pacific. As a result, patients are increasingly seeking timely diagnosis and intervention, fueling the demand for specialized treatment modalities and driving market growth.

Active Key Players in the Plantar Fasciitis Treatment Market

• 3M
• A. Algeo Ltd.
• Bauerfeind USA Inc.
• Hanger, Inc.
• OrthoBethesda
• OrthoMed, Inc.
• Ottobock
• Pfizer, Inc.
• Revance Therapeutics, Inc.
• Sanofi
• Shapecrunch
• Other Key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Plantar Fasciitis Treatment Market by Treatment Type
 4.1 Plantar Fasciitis Treatment Market Snapshot and Growth Engine
 4.2 Plantar Fasciitis Treatment Market Overview
 4.3 Therapy
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Therapy: Geographic Segmentation Analysis
 4.4 Medication therapy
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Medication therapy: Geographic Segmentation Analysis
 4.5 surgery
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 surgery: Geographic Segmentation Analysis

Chapter 5: Plantar Fasciitis Treatment Market by Indication
 5.1 Plantar Fasciitis Treatment Market Snapshot and Growth Engine
 5.2 Plantar Fasciitis Treatment Market Overview
 5.3 Mild
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Mild: Geographic Segmentation Analysis
 5.4 Moderate
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Moderate: Geographic Segmentation Analysis
 5.5 Severe
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Severe: Geographic Segmentation Analysis

Chapter 6: Plantar Fasciitis Treatment Market by End-user
 6.1 Plantar Fasciitis Treatment Market Snapshot and Growth Engine
 6.2 Plantar Fasciitis Treatment Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Orthopedic clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Orthopedic clinics: Geographic Segmentation Analysis
 6.5 Physiotherapy centers
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Physiotherapy centers: Geographic Segmentation Analysis
 6.6 Other end-users
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Other end-users: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Plantar Fasciitis Treatment Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 3M
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 A ALGEO LTD
 7.4 BAUERFEIND USA INC
 7.5 HANGER INC
 7.6 ORTHOBETHESDA
 7.7 ORTHOMED INC
 7.8 OTTOBOCK
 7.9 PFIZER INC
 7.10 REVANCE THERAPEUTICS INC
 7.11 SANOFI
 7.12 SHAPECRUNCH
 7.13 OTHER ACTIVE PLAYERS

Chapter 8: Global Plantar Fasciitis Treatment Market By Region
 8.1 Overview
 8.2. North America Plantar Fasciitis Treatment Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Treatment Type
   8.2.4.1 Therapy
   8.2.4.2 Medication therapy
   8.2.4.3 surgery
  8.2.5 Historic and Forecasted Market Size By Indication
   8.2.5.1 Mild
   8.2.5.2 Moderate
   8.2.5.3 Severe
  8.2.6 Historic and Forecasted Market Size By End-user
   8.2.6.1 Hospitals
   8.2.6.2 Orthopedic clinics
   8.2.6.3 Physiotherapy centers
   8.2.6.4 Other end-users
  8.2.7 Historic and Forecast Market Size by Country
   8.2.7.1 US
   8.2.7.2 Canada
   8.2.7.3 Mexico
 8.3. Eastern Europe Plantar Fasciitis Treatment Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Treatment Type
   8.3.4.1 Therapy
   8.3.4.2 Medication therapy
   8.3.4.3 surgery
  8.3.5 Historic and Forecasted Market Size By Indication
   8.3.5.1 Mild
   8.3.5.2 Moderate
   8.3.5.3 Severe
  8.3.6 Historic and Forecasted Market Size By End-user
   8.3.6.1 Hospitals
   8.3.6.2 Orthopedic clinics
   8.3.6.3 Physiotherapy centers
   8.3.6.4 Other end-users
  8.3.7 Historic and Forecast Market Size by Country
   8.3.7.1 Bulgaria
   8.3.7.2 The Czech Republic
   8.3.7.3 Hungary
   8.3.7.4 Poland
   8.3.7.5 Romania
   8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Plantar Fasciitis Treatment Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Treatment Type
   8.4.4.1 Therapy
   8.4.4.2 Medication therapy
   8.4.4.3 surgery
  8.4.5 Historic and Forecasted Market Size By Indication
   8.4.5.1 Mild
   8.4.5.2 Moderate
   8.4.5.3 Severe
  8.4.6 Historic and Forecasted Market Size By End-user
   8.4.6.1 Hospitals
   8.4.6.2 Orthopedic clinics
   8.4.6.3 Physiotherapy centers
   8.4.6.4 Other end-users
  8.4.7 Historic and Forecast Market Size by Country
   8.4.7.1 Germany
   8.4.7.2 UK
   8.4.7.3 France
   8.4.7.4 Netherlands
   8.4.7.5 Italy
   8.4.7.6 Russia
   8.4.7.7 Spain
   8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Plantar Fasciitis Treatment Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Treatment Type
   8.5.4.1 Therapy
   8.5.4.2 Medication therapy
   8.5.4.3 surgery
  8.5.5 Historic and Forecasted Market Size By Indication
   8.5.5.1 Mild
   8.5.5.2 Moderate
   8.5.5.3 Severe
  8.5.6 Historic and Forecasted Market Size By End-user
   8.5.6.1 Hospitals
   8.5.6.2 Orthopedic clinics
   8.5.6.3 Physiotherapy centers
   8.5.6.4 Other end-users
  8.5.7 Historic and Forecast Market Size by Country
   8.5.7.1 China
   8.5.7.2 India
   8.5.7.3 Japan
   8.5.7.4 South Korea
   8.5.7.5 Malaysia
   8.5.7.6 Thailand
   8.5.7.7 Vietnam
   8.5.7.8 The Philippines
   8.5.7.9 Australia
   8.5.7.10 New Zealand
   8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Plantar Fasciitis Treatment Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Treatment Type
   8.6.4.1 Therapy
   8.6.4.2 Medication therapy
   8.6.4.3 surgery
  8.6.5 Historic and Forecasted Market Size By Indication
   8.6.5.1 Mild
   8.6.5.2 Moderate
   8.6.5.3 Severe
  8.6.6 Historic and Forecasted Market Size By End-user
   8.6.6.1 Hospitals
   8.6.6.2 Orthopedic clinics
   8.6.6.3 Physiotherapy centers
   8.6.6.4 Other end-users
  8.6.7 Historic and Forecast Market Size by Country
   8.6.7.1 Turkey
   8.6.7.2 Bahrain
   8.6.7.3 Kuwait
   8.6.7.4 Saudi Arabia
   8.6.7.5 Qatar
   8.6.7.6 UAE
   8.6.7.7 Israel
   8.6.7.8 South Africa
 8.7. South America Plantar Fasciitis Treatment Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Treatment Type
   8.7.4.1 Therapy
   8.7.4.2 Medication therapy
   8.7.4.3 surgery
  8.7.5 Historic and Forecasted Market Size By Indication
   8.7.5.1 Mild
   8.7.5.2 Moderate
   8.7.5.3 Severe
  8.7.6 Historic and Forecasted Market Size By End-user
   8.7.6.1 Hospitals
   8.7.6.2 Orthopedic clinics
   8.7.6.3 Physiotherapy centers
   8.7.6.4 Other end-users
  8.7.7 Historic and Forecast Market Size by Country
   8.7.7.1 Brazil
   8.7.7.2 Argentina
   8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research